Here are three stocks that may be appropriately held in a basket of stocks intended to participate in the future of medicine says Enriched Investing’s Margaret Samuel.

It’s a disturbing thought,   Read More

“Bricks and mortar will still remain very, very important . . . consumers are very interested in getting back to the stores” says Scotiabank’s Patricia Baker.

With rising consumer spending high   Read More

Here are three stocks that may be appropriately held in a basket of stocks intended to participate in the future of medicine says Enriched Investing’s Margaret Samuel.

It’s a disturbing thought,   Read More

“Bricks and mortar will still remain very, very important . . . consumers are very interested in getting back to the stores” says Scotiabank’s Patricia Baker.

With rising consumer spending high   Read More

Cardiol Therapeutics seeks to save the pandemic’s most vulnerable—those with pre-existing medical conditions and risk factors.

For most Canadians, a successful COVID-19 vaccination will put an end to the crisis that   Read More

Cardiol Therapeutics seeks to save the pandemic’s most vulnerable—those with pre-existing medical conditions and risk factors.

For most Canadians, a successful COVID-19 vaccination will put an end to the crisis that   Read More

Danavation Technologies’ Digital Smart Labels™ enable companies to automate labelling, price, product information and promotions in real time.

New technological innovations often lead to rapid changes in previously stable systems. Recall   Read More

These three income trusts were featured in Investor’s Digest recent survey of Canada’s most widely covered income trusts.
Chartwell Retirement Residences (TSX—CSH.UN)
So far in 2021, some of the retail and diversified   Read More

Savaria Corp.’s shares have risen to reflect its acquisition of Sweden-based Handicare Group.

Savaria’s acquisition of Handicare Group is in an industry it knows well. The company “designs, manufactures, distributes, and   Read More

Long-term care homes have been hit hard by the pandemic. But there could be some “interesting” announcements in 2021’s first half, however.

CIBC analysts hosted a panel of leaders and advisors   Read More

Long-term care homes have been hit hard by the pandemic. But there could be some “interesting” announcements in 2021’s first half, however.

CIBC analysts hosted a panel of leaders and advisors   Read More

Odlum Brown’s Murray Leith names five stocks with relatively attractive risk-return characteristics. He begins with some thoughts on Christmas dinner.

In the Leith household, we sometimes turn dinner on its head   Read More

Here are three junior cannabis stocks recommended by analysts as ‘buys’. They serve a mix of medical and recreational marijuana markets for their products.
Indus Holdings Inc. (CNSX—INDS)
Beacon Securities analyst Doug   Read More

Haywood Securities analyst Neal Gilmer picks two US-based marijuana stocks to buy for their pent-up recreational demand.

Toronto-based equity analyst Neal Gilmer observes that although the United States Controlled Substances Act   Read More

Toronto-based Raymond James analysts Rahul Sarugaser and Michael Freeman say the strong cannabis stocks are beginning to separate from the weak. They pick two to buy.
Fundamentals are improving across the   Read More

Here are two healthcare stocks to buy. One is an owner and operator of healthcare clinics; the other a biotechnology supplier of custom antibodies.
WELL Health Technologies Corp. (TSX—WELL)
Healthcare stock WELL   Read More

Mackie Research analysts Andre Uddin and Yue “Toby” Ma recently reviewed three junior healthcare stocks that they rate as ‘speculative buys’.
Appili Therapeutics Inc. (TSX—APLI)
Founded to advance the global fight against   Read More

A manufacturer of higher-value, higher-margin edible, vape and beverage products and a provider of incision-free therapies for the treatment of prostate cancer are “strong buys”.

Before this year’s stock market correction,   Read More

A manufacturer of higher-value, higher-margin edible, vape and beverage products and a provider of incision-free therapies for the treatment of prostate cancer are “strong buys”.

Before this year’s stock market correction,   Read More

HealthSpace Data Systems promises to deliver its platform for contact tracing within 48 hours to any North American jurisdiction fighting COVID-19 outbreaks.

The rush to collect and measure medically relevant data   Read More

COVID-19 has had a mixed impact on Procter & Gamble’s business. Despite this, the company reported higher earnings in its latest quarter and increased its dividend.

There’s an old saying: “What   Read More

Capital Group Global Equity fund has been a stellar fund over the years. But it’s not resting on its laurels. The fund is adjusting its portfolio in response to the   Read More

The COVID-19 pandemic has increased demand for groceries and other essentials. Loblaw same-store sales are expected to benefit from this demand.

Grocery companies have offered investors shelter in turbulent markets. A   Read More

Seasonality analyst names this conservative ETF, with a basket of diversified international healthcare stocks (which, he says, trumps all other market sectors), as his current ‘best buy’.

Market volatility will be   Read More

Laurentian analyst predicts that after a difficult 2019, troubled marijuana stocks will find their redemption, particularly his “preferred pick” selection, Aurora Cannabis Inc.

Turnaround stories often coincide with the start of   Read More

With the slow rollout of cannabis stores in Ontario, pot stocks have been beaten down. But that has made some of them more attractively valued.

After initially getting upset at Aphria   Read More

Oil and gas exploration and the emergence of a new coronavirus make for strange bedfellows in Contra the Heard’s Benj Gallander’s choice of his two current best buys.
While stock markets   Read More

Healthcare stock Extendicare operates over 120 long-term care and retirement home facilities across Canada and runs its home care business through 35 branches across the country.

Healthcare stock Extendicare Inc. (TSX—EXE)   Read More

With the slow rollout of cannabis stores in Ontario, pot stocks have been beaten down. But that has made some of them more attractively valued.

After initially getting upset at Aphria   Read More

Laurentian analyst predicts that after a difficult 2019, troubled marijuana stocks will find their redemption, particularly his “preferred pick” selection, Aurora Cannabis Inc.

Turnaround stories often coincide with the start of   Read More

Curaleaf is one of the largest vertically-integrated cannabis companies in the US. Organic vertical integration is a key strategy.

Curaleaf Holdings Inc. (CNSX—CURA) reports record numbers (not uncommon for fledgling marijuana   Read More

Earnings outlooks for 2020 have set the prices of manufacturing stocks AG Growth International and Medtronic plc.
The shares of manufacturing stock AG Growth International (TSX—AFN) fell substantially in August, giving   Read More

We’ve added Mackenzie Canadian Growth Fund to our Recommended Mutual Funds list.
Mackenzie Canadian Growth Fund (Fund codes: MFC650(FE), MFC640(BE), MFC7028(LL)) invests mainly in Canadian stocks to achieve long-term capital growth   Read More

Jamieson Wellness manufactures branded natural health products including vitamins, minerals, and supplements. CIBC World Markets says it’s an “outperformer”.

Hoping to inject health into your bank account too, Toronto-based CIBC World   Read More

Given that we consider the Canadian dollar to be undervalued in relation to the US dollar, we generally recommend you hedge your currency risk when investing south of the border.

Despite   Read More

Portfolio manager and financial analyst John Kim picks two US blue chip stocks as his current ‘best buys’: CVS Health Corp. and AT&T Inc.
Caution is the name of the game   Read More

A recent survey by The MoneyLetter of securities analysts’ reports found two junior cannabis-related stocks favored by Toronto-based Mackie Research Capital.
Toronto-based Mackie Research analyst Nikhil Thadani initiated coverage of technology   Read More

Healthcare stock Abacus Health Products develops and commercializes over-the-counter topical pain relief and therapeutic skincare products.
Abacus Health Products Inc. (CNSX—ABCS) is poised to become a leader in the topical pain   Read More

While drugs and gold were the two most popular forms of payment for votes in the recent election in India, portfolio manager Elvis Picardo proffers far better reasons for picking   Read More

While drugs and gold were the two most popular forms of payment for votes in the recent election in India, portfolio manager Elvis Picardo proffers far better reasons for picking   Read More

“Being able to perform in line or better than the market while holding almost a third in cash suggests that our stock picking and trading strategy have provided positive alpha   Read More

Consumer goods stock Johnson & Johnson faces a public relations nightmare that could cost it billions. From a purely financial viewpoint, however, this global stock remains a buy.
US stock Johnson   Read More

Analyst Alp Erdogan says that in 2019, capital that bloated the 2018 prices of cryptocurrencies, cannabis stocks and blockchain technology generally will shift toward value stocks with better defensive characteristics.   Read More

We’ve added a new fund to our recommended Conservative Canadian Stock Funds on the Money Reporter’s ‘The Top 40: Canada’s Best Mutual Funds’ list. Mackenzie Canadian Growth Fund’s investment approach   Read More

Canntab Therapeutics Inc. has developed a process to incorporate cannabis extracts into pills that administer measured, standardized dosages, and include a unique delivery system to enable time-controlled absorption. Investor’s Digest   Read More

Open Text has improved the quality of its revenues by increasing the amount of recurring revenues it earns. Higher-quality revenues should help it to continue to deliver the cash flows   Read More

Vancouver-based PI Financial Corp. analysts Bob Gibson, Jason Zandberg and Devin Schilling recently teamed up to review their most recent list of ‘top stock picks’ for Investor’s Digest of Canada.   Read More

We’ve added a new fund to our recommended Conservative Canadian Stock Funds on the Money Reporter’s ‘The Top 40: Canada’s Best Mutual Funds’ list. Mackenzie Canadian Growth Fund’s investment approach   Read More

Investor’s Digest of Canada contributors Doug Cooper and David Kideckel, Toronto-based Beacon Securities equity analysts, argue the United States is in the midst of a pot revolution. Americans are hankering   Read More

A junior marijuana start-up has just closed a deal to buy an enormous former food plant facility in Cobourg, Ontario, that spans 27 acres and once manufactured cereals, dog food,   Read More

‘Where there’s smoke, there’s . . . opportunity’ concludes The MoneyLetter after surveying a number of security analysts’ reports on medical cannabis producers in Canada. Companies already established in the   Read More

Cardinal Health’s problems with Cordis, plus the negative impact of generic drug pricing on company profits, has given us pause on this healthcare stock. We recommend that purchases be deferred   Read More